ENTITY

Innovent Biologics Inc (1801 HK)

342

Analysis

Health Care • China

Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.

more

Refresh

Company Event • 17 Nov 2021 17:00 • Latest

Smartkarma Webinar | Potential Inclusions to the Hang Seng Index (HSI INDEX)

No more events

x

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Innovent Biologics Inc (1801 HK)

Smartkarma Webinar | Potential Inclusions to the Hang Seng Index (HSI INDEX)

The webinar will be hosted on Wednesday, 17 November 2021, 17:00 SGT/HKT.

Register for the Webinar here

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)